CRISPR THERAPEUTICS AG earnings per share and revenue

CRSP/N earnings per share for the last quarter are -23.70 MXN whereas the estimation was -22.55 MXN which accounts for -5.08% surprise. Företagets omsättning för samma period uppgår till 8.35 M MXN trots den uppskattade siffran 381.94 M MXN. Estimated earnings per share for the next quarter are -26.37 MXN, and revenue is expected to reach 229.35 M MXN. Also watch annual changes over time to get a bigger picture of CRSP/N earnings per share and revenue dynamics.